EUVIMEDEUVIMED entdecken
Crossref

In silico validation of human N-myc downstream-regulated gene 2 protein against Alzheimer's disease using molecular modeling, docking and dynamics studies

Aathi Muthusankar, Piramanayagam Shanmughavel

Drug Invention Today · 2013

DOI: 10.1016/j.dit.2013.02.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Invention Today, 2013. Verfasst von Aathi Muthusankar und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Muthusankar, A., & Shanmughavel, P. (2013). In silico validation of human N-myc downstream-regulated gene 2 protein against Alzheimer's disease using molecular modeling, docking and dynamics studies. Drug Invention Today. https://doi.org/10.1016/j.dit.2013.02.002

Vancouver

Muthusankar A, Shanmughavel P. In silico validation of human N-myc downstream-regulated gene 2 protein against Alzheimer's disease using molecular modeling, docking and dynamics studies. Drug Invention Today. 2013. doi:10.1016/j.dit.2013.02.002

BibTeX
@article{Muthusankar2013,
  author = {Muthusankar, Aathi and Shanmughavel, Piramanayagam},
  title = {In silico validation of human N-myc downstream-regulated gene 2 protein against Alzheimer's disease using molecular modeling, docking and dynamics studies},
  journal = {Drug Invention Today},
  year = {2013},
  doi = {10.1016/j.dit.2013.02.002}
}
Kostenlos starten →